BioHarvest Sciences Operating Income 2020-2024 | BHST
BioHarvest Sciences operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
BioHarvest Sciences Annual Operating Income (Millions of US $) |
2023 |
$-10 |
2022 |
$-11 |
2021 |
$-8 |
2020 |
$-6 |
2019 |
$-2 |
2019 |
$-4 |
2018 |
$-4 |
BioHarvest Sciences Quarterly Operating Income (Millions of US $) |
2024-06-30 |
$-2 |
2024-03-31 |
$-1 |
2023-12-31 |
$-3 |
2023-09-30 |
$-2 |
2023-06-30 |
$-3 |
2023-03-31 |
$-3 |
2022-12-31 |
$-3 |
2022-09-30 |
$-3 |
2022-06-30 |
$-2 |
2022-03-31 |
$-3 |
2021-12-31 |
$-1 |
2021-09-30 |
$-3 |
2021-06-30 |
$-2 |
2021-03-31 |
$-2 |
2020-12-31 |
$-2 |
2020-09-30 |
$-2 |
2020-06-30 |
$-1 |
2020-03-31 |
$-1 |
2019-12-31 |
|
2019-09-30 |
$-1 |
2019-06-30 |
$-0 |
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|